CRISPR-Cas is an adaptive immunity system in prokaryotes that functions via a unique mechanism which involves incorporation of foreign DNA fragments into CRISPR arrays and subsequent utilization of transcripts of these inserts (known as spacers) as guide RNAs to cleave the cognate selfish element genome. Multiple attempts have been undertaken to explore the coevolution of viruses and microbial hosts carrying CRISPR-Cas using mathematical models that employ either systems of differential equations or an agent-based approach, or combinations thereof. Analysis of these models reveals highly complex co-evolutionary dynamics that ensues from the combination of the heritability of the CRISPR-mediated adaptive immunity with the existence of different degrees of immunity depending on the number of cognate spacers and the cost of carrying a CRISPR-Cas locus. Depending on the details of the models, a variety of testable, sometimes conflicting predictions have been made on the dependence of the degree of immunity and the benefit of maintaining CRISPR-Cas on the abundance and diversity of hosts and viruses. Some of these predictions have already been directly validated experimentally. In particular, both the reality of the virus-host arms race, with viruses escaping resistance and hosts reacquiring it through the capture of new spacers, and the fitness cost of CRISPR-Cas due to the curtailment of beneficial HGT have been reproduced in the laboratory. However, to test the predictions of the models more specifically, detailed studies of coevolving populations of microbes and viruses both in nature and in the laboratory are essential. Such analyses are expected to yield disagreements with the predictions of the current, oversimplified models and to trigger a new round of theoretical developments.
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CRISPR-Cas: heritable adaptive immunity in archaea and bacteria
All cellular life forms on earth evolve under an incessant assault from viruses and other selfish genetic elements which translates into a perennial arms race [1] [2] [3] . In the course of this arms race, cellular organisms have evolved elaborate networks of diverse, interconnected defense systems [4] [5] [6] . Historically, the best known of such defense mechanisms is the adaptive immunity in vertebrates that over the decades had been characterized in exquisite detail [7] [8] [9] . The key feature of adaptive immunity is immunological memory that often lasts through the lifetime of an individual, providing extremely efficient resistance against a specific, previously encountered, pathogen, but is not transmitted across generations. More recently, it has become clear that all organisms possess multiple mechanisms of innate immunity that do not involve immunological memory but instead provide non-specific protection against entire classes of pathogens that is often less efficient than the protection attained via adaptive immunity 10, 11 . Bacteria and archaea (collectively, prokaryotes)
have been long known to possess innate immunity that includes in particular the thoroughly characterized restriction-modification systems; moreover, recent advances in comparative genomics and experimental study of virus-host interaction have revealed a variety of new defense mechanisms 6, [12] [13] [14] [15] . Until recently, prokaryotes have not been thought to possess adaptive immunity but this belief was dramatically overturned with the discovery of the defense system that became known as CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas (CRISPRassociated genes) [16] [17] [18] [19] [20] .
The CRISPR-Cas system functions via a unique mechanism that involves incorporation of foreign DNA fragments into CRISPR repeat arrays and subsequent utilization of transcripts of these inserts (known as spacers) as guide RNAs to cleave the cognate selfish element genome [21] [22] [23] [24] [25] . These processes are catalyzed or facilitated by complexes of multiple Cas proteins that are typically encoded in close proximity of the CRISPR cassettes. The mechanism of CRISPR-Cas is usually divided into three stages: 1) adaptation, when new 30-84 base pair long, unique spacers homologous to proto-spacer sequences in viral genomes or other alien DNA molecules are integrated into the CRISPR repeat cassettes; 2) expression and processing of pre-crRNA into short guide crRNAs; and 3) interference, when the alien DNA or RNA is targeted by a complex of Cas proteins containing a crRNA guide and cleaved within the unique target site 5, 20, 26, 27 .
The defense provided by CRISPR-Cas is highly specific: a single nucleotide substitution in a "seed" region of a spacer often abrogates immunity 28 . The protection against infectious elements is also extremely efficient, with the yield of the cognate virus dropping by up to 5 orders of magnitude which effectively amounts to complete resistance 19, 29 . The CRISPR-Cas systems are endowed with immunological memory that is ensured by the persistence of the spacers that can be transmitted across many thousands of prokaryotic cell generations. Thus, the CRISPR-Cas systems meet all the criteria for adaptive (acquired) immunity 30 .
In the few years that elapsed since the seminal discovery of the CRISPR mechanism, the CRISPR research evolved into a highly dynamic field of microbiology with major potential for applications in epidemiology, biotechnology and genome engineering 27, 31, 32 . Multiple applications of CRIPSR-Cas for genome manipulation and gene expression programming already have been developed [33] [34] [35] [36] .
The CRISPR-Cas systems display an enormous diversity of Cas protein repertoires and the architectures of the respective genomic loci. Comparative analysis of the sequences and structures of Cas proteins, combined with the analysis of genomic architectures, led to the classification of the CRISPR-Cas systems into three distinct types (I, II and III) that include 10 subtypes and a growing number of still unclassified, less common variants 5 .
A major distinction between CRISPR-Cas and animal immune systems is that CRISPRCas modifies the host genome in response to infection and hence provides heritable immunity.
Indeed, CRISPR-Cas is the most compelling known case for Lamarckian inheritance whereby an organism responds to an environmental cue (in this case, invasion of foreign DNA) by generating a heritable modification of the genome that provides specific adaptive response to the original challenge 37 .
The benefit of highly specific and efficient resistance to selfish elements enjoyed by the organisms that carry CRISPR-cas loci appears to be countered by potential fitness cost 38, 39 . One likely source of the cost is autoimmunity whereby a CRISPR cassette accidentally incorporates a spacer homologous to the host DNA, with obvious deleterious consequences 40, 41 . This phenomenon is strikingly similar to animal autoimmunity. The other and perhaps more important source of cost does not involve any errors and appears to be inherent to the CRISPR-Cas mechanism. This potential drawback of CRISPR-Cas involves curtailment of the capture of new genes via horizontal gene transfer (HGT) that is likely to accompany the defensive action of 47 . Rapid acquisition and loss of CRISPR spacers leading to intra-population heterogeneity also has been observed in experiments on both archaeal 55 and bacterial 56 models.
Viruses can evade CRISPR-Cas through minimal mutational or recombinational changes in proto-spacers (the sequences in the viral genome that are excised by the Cas machinery to become spacers). In some bacteria, a single proto-spacer mutation renders CRISPR-Cas ineffectual 29, 57, 58 although other CRISPR-Cas systems show less rigid specificity 28 . The hosts can regain antiviral immunity by acquiring new spacers from the same viral genome [57] [58] [59] [60] . The restoration of immunity is facilitated by an ancillary mechanism dubbed priming whereby spacers derived from a given virus or plasmid genome, even after losing their direct protective capacity, substantially enhance acquisition of new spacers from the same. Together, viral evasion of immunity and loss and regain of immune spacers and entire CRISPR-cas loci by prokaryotes drive a co-evolutionary arms race between the mutating virus and the spacer-incorporating host. This arms race can go multiple rounds and take unexpected forms as illustrated by the finding that certain bacteriophages encode their own CRISPR-Cas system which targets host innate immunity loci, thus exploiting a host defense mechanism for counter-defense 61 .
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The virus-host arms race combined with the horizontal mobility of the CRISPR-cas loci results in complex co-evolutionary dynamics. It is well known from decades of studies in ecology, starting with the classic work of Lotka and Volterra, that mathematical modeling of prey-predator or host-parasite coevolution can clarify the co-evolutionary dynamics and reveal non-trivial evolutionary regimes [62] [63] [64] . Therefore multiple attempts to model the coevolution of CRISPR-cas carrying hosts and viruses have been undertaken shortly after the molecular characterization of CRISPR-Cas. Here we discuss these models, the predictions they make regarding the population dynamics of viruses and hosts, and various co-evolutionary regimes, and the first attempts on experimental validation of these predictions.
Mathematical models of CRISPR-Cas-virus coevolution and the first experimental tests
The arms race between the immune system and viruses, the common events of loss and horizontal transfer of CRISPR-Cas loci and the fitness cost that is apparently incurred by CRISPR-Cas combine to yield complex evolutionary dynamics. However, this dynamics could be simplified by the extremely high efficacy of the CRISPR-Cas-mediated immunity which decreases the virus yield by as much as 5 orders of magnitude. Given this level of immunity, the host population can be reasonably approximated by partitioning into resistant and sensitive subpopulations. This type of dynamic provides fertile ground for mathematical modeling with a potential to elucidate the interactions between different evolutionary processes and possibly discover unexpected evolutionary regimes. The mathematical models of CRISPR-Cas coevolution that have been independently developed by several research groups focused on explaining the striking features of the CRISPR-Cas systems that became apparent through comparative genomic analyses, namely their fast evolution, enormous diversity of the spacers and gene arrangements in the cas operons, and the old (distal from the leader) end uniformity.
Most of the models belong to one of the two classes according to the type of abstractions that are used to represent the agents and their interactions ( Table 1 ). The first approach employs systems of differential equations (SDE) in which the coevolving entities, i.e. host and virus strains, are
represented by their abundances. The interactions of these entities with each other and with the environment are represented as rates of change. The SDE models can be analyzed numerically or Fluctuation experiments show that the CRISPR deletion mutants are not induced by the plasmids but rather pre-exist, being produced at high rates (>10 −4 per cell per generation). These findings 
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Lamarckian adaptive evolution: this mode of evolution is advantageous under conditions of intense environmental pressure that, however, does not exceed a threshold beyond which organisms lose the ability to track the changes in the environment.
In a subsequent refinement of the strain-based ABS approach, Iranzo et al. explored the population dynamics of viruses and hosts in the course of coevolution 71 . The results indicate that generally, virus diversity dramatically increases with the virus population size which itself grows with the host population size. Therefore, even at equal mutation rates, the efficacy of CRISPRbased immunity is predicted to be limited in environments that support larger host and virus 
Conclusions
The efforts on mathematical modeling of CRISPR-mediated immunity are only 4 years old but by capitalizing on the extensive earlier work on predator-prey dynamics and parasite-host coevolution, a lot of ground has already been covered. The models converge on several key findings that broadly agree with qualitative observations from comparative genomic analyses. In particular, it has become clear that the combination of the heritability of the CRISPR-mediated adaptive immunity with the existence of different degrees of immunity depending on the number of cognate spacers and the cost of carrying a CRISPR-Cas locus translates into a highly complex co-evolutionary dynamics. This dynamics includes oscillations of the host and virus population size that might be intrinsically unpredictable (quasi-chaotic) 66 . Depending on the details of the models, a variety of testable, sometimes conflicting predictions have been made on the 
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dependence of the degree of immunity and the benefit of maintaining CRISPR-Cas on the abundance and diversity of hosts and viruses. In particular, contrary to the naïve expectation that the benefit of CRISPR-Cas would increase proportional to the virus diversity, model analysis has suggested that the maximum activity and efficacy of CRISPR-Cas are expected at intermediate virus diversity 39 , a prediction that remains to be tested experimentally.
Some of the key results of mathematical modeling have already been directly validated experimentally. Thus, it has been shown that the virus-host arms race, with viruses escaping resistance and hosts reacquiring it through the capture of new spacers is a tangible reality that can be reproduced in the laboratory 65 . Moreover, the fitness cost incurred by CRISPR-Cas due to the curtailment of beneficial HGT also has been observed experimentally and shown to result in frequent loss of the CRISPR-Cas loci and competition between CRISPR-Cas and other, in particular phenotypic, resistance mechanisms 68 . These findings are broadly compatible with the extremely patchy distribution of CRISPR-Cas among the available archaeal and bacterial genomes 6 . However, comparative genomic analysis at the level of species or even strains of bacteria and archaea might not be particularly informative for understanding the microevolutionary dynamics predicted by the mathematical models of CRISPR-Cas because the key events occur at the population level 77 . Therefore, in order to test the predictions of the models, detailed studies of coevolving microbes and viruses both in nature and in the laboratory are essential. Beyond doubt, such analyses will yield disagreements with the predictions of the current, oversimplified models, stimulating a new round of theoretical developments. 
